X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery

Publisher： John Wiley & Sons Inc

E-ISSN： 1878-0261|12|1|33-47

ISSN： 1574-7891

Source： Molecular Oncology, Vol.12, Iss.1, 2018-01, pp. : 33-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful hematopoietic cell transplantation in a patient with X‐linked agammaglobulinemia and acute myeloid leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 9, 2015-09 ,pp. : 1674-1676

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Induction of apoptosis by obovatol as a novel therapeutic strategy for acute myeloid leukemia

By  

International Journal of Molecular Medicine, Vol. 34, Iss. 6, 2014-01 ,pp. : 1675-1680

Spandidos Publications

Access to resources Recommend Favorite

Sensitization of Glioma Cells by X-Linked Inhibitor of Apoptosis Protein Knockdown

By  

Oncology, Vol. 83, Iss. 2, 2012-06 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 796-799

John Wiley & Sons Inc

Access to resources Recommend Favorite